From: The clinical use of biomarkers as prognostic factors in Ewing sarcoma
Author | Year | Biomarker | Pt number | P |
---|---|---|---|---|
Rutkowski et al, J Surg Oncol 84, 151-9[27] | 2003 | IL-1ra | 13 | 0.0001 |
Rutkowski et al, J Surg Oncol 84, 151-9[27] | 2003 | sIL-2ra | 13 | 0.005 |
Rutkowski et al, J Surg Oncol 84, 151-9[27] | 2003 | IL-6 | 13 | 0.001 |
Rutkowski et al, J Surg Oncol 84, 151-9[27] | 2003 | IL-8 | 13 | 0.0001 |
Rutkowski et al, J Surg Oncol 84, 151-9[27] | 2003 | IL-10 | 13 | 0.01 |
Rutkowski et al, J Surg Oncol 84, 151-9[27] | 2003 | TNF RI | 13 | 0.001 |
Rutkowski et al, J Surg Oncol 84, 151-9[27] | 2003 | TNF RII | 13 | 0.01 |
Rutkowski et al, J Surg Oncol 84, 151-9[27] | 2003 | M-CSF | 13 | 0.01 |
Berghuis et al, J Pathol 218, 222-31[66] | 2009 | HLA class I | 67 | NS |